Literature DB >> 12151397

Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling.

Vladimir S Spiegelman1, Weigang Tang, Andrew M Chan, Makoto Igarashi, Stuart A Aaronson, David A Sassoon, Masaru Katoh, Thomas J Slaga, Serge Y Fuchs.   

Abstract

Homologue of Slimb (HOS) is the substrate-recognizing component of the SCF(HOS)-Roc1 E3 ubiquitin protein ligase. This ligase mediates ubiquitination of the inhibitor of NF-kappaB transcription factor (IkappaB). We have found that HOS is highly expressed in a number of human cancer cell lines. The rates of the HOS gene transcription as well as HOS mRNA and protein levels were up-regulated in cells treated with mitogens or transfected with the inducers of mitogen-activated protein kinase pathway. Conversely, mitogen withdrawal strikingly reduced HOS levels during differentiation of mouse myoblasts. Activators of mitogen-activated protein kinase accelerated IkappaBalpha degradation and increased NF-kappaB transcriptional activity. Inhibition of HOS function via expression of dominant negative HOS (HOS(DeltaF)) initiated mouse myoblast differentiation and prevented Ras-mediated acceleration of IkappaBalpha degradation as well as NF-kappaB trans-activation and transformation of NIH3T3 cells. These data link the induction of HOS in proliferating cells with mitogen-signaling-dependent inhibition of cell differentiation and promotion of cell transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151397     DOI: 10.1074/jbc.M204524200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

2.  Melanoma cell-secreted soluble factor that stimulates ubiquitination and degradation of the interferon alpha receptor and attenuates its signaling.

Authors:  Wei-Chun HuangFu; Juan Qian; Chengbao Liu; Hallgeir Rui; Serge Y Fuchs
Journal:  Pigment Cell Melanoma Res       Date:  2010-12       Impact factor: 4.693

Review 3.  E3 ubiquitin ligases as cancer targets and biomarkers.

Authors:  Yi Sun
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

4.  Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.

Authors:  J Liu; K G Suresh Kumar; D Yu; S A Molton; M McMahon; M Herlyn; A Thomas-Tikhonenko; S Y Fuchs
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

5.  Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells.

Authors:  K G Suresh Kumar; Jianghuai Liu; Ying Li; Duonan Yu; Andrei Thomas-Tikhonenko; Meenhard Herlyn; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2007-06-13       Impact factor: 4.742

6.  Impaired turnover of prolactin receptor contributes to transformation of human breast cells.

Authors:  Alexandr Plotnikov; Bentley Varghese; Thai H Tran; Chengbao Liu; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  β-Transducin repeat-containing protein 1 (β-TrCP1)-mediated silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) protein degradation promotes tumor necrosis factor α (TNFα)-induced inflammatory gene expression.

Authors:  Kuo-Sheng Hsu; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

8.  Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesis.

Authors:  Yasusei Kudo; Daniele Guardavaccaro; Patricia G Santamaria; Ryo Koyama-Nasu; Esther Latres; Roderick Bronson; Lili Yamasaki; Michele Pagano
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

Authors:  K G Suresh Kumar; Weigang Tang; Abhilash K Ravindranath; William A Clark; Ed Croze; Serge Y Fuchs
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.